Correlation Between Maxigen Biotech and Nova Technology

Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and Nova Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and Nova Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maxigen Biotech and Nova Technology, you can compare the effects of market volatilities on Maxigen Biotech and Nova Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of Nova Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and Nova Technology.

Diversification Opportunities for Maxigen Biotech and Nova Technology

0.4

Correlation Coefficient

Maxigen Biotech  Nova Technology

Very weak diversification

The 3 months correlation between Maxigen and Nova is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and Nova Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nova Technology and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with Nova Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nova Technology has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and Nova Technology go up and down completely randomly.

Pair Corralation between Maxigen Biotech and Nova Technology

Assuming the 90 days trading horizon Maxigen Biotech is expected to generate 2.47 times less return on investment than Nova Technology. But when comparing it to its historical volatility, Maxigen Biotech is 1.55 times less risky than Nova Technology. It trades about 0.08 of its potential returns per unit of risk. Nova Technology is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  15,669  in Nova Technology on April 25, 2025 and sell it today you would earn a total of  2,481  from holding Nova Technology or generate 15.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Maxigen Biotech  vs.  Nova Technology

Maxigen Biotech

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Nova Technology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nova Technology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Nova Technology showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Maxigen Biotech and Nova Technology

The main advantage of trading using opposite Maxigen Biotech and Nova Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, Nova Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nova Technology will offset losses from the drop in Nova Technology's long position.

The idea behind Maxigen Biotech and Nova Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.